Integra Essentia Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 9:44 pm

Competitors of Integra Essentia Ltd

All Competitor Stocks of Integra Essentia Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:55 am

Below is a detailed analysis of the quarterly data for Integra Essentia Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 78.73 Cr.. The value appears to be declining and may need further review. It has decreased from 99.94 Cr. (Mar 2025) to 78.73 Cr., marking a decrease of 21.21 Cr..
• For Expenses, as of Jun 2025, the value is 77.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 99.91 Cr. (Mar 2025) to 77.71 Cr., marking a decrease of 22.20 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.03 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.99 Cr..
• For OPM %, as of Jun 2025, the value is 1.30%. The value appears strong and on an upward trend. It has increased from 0.03% (Mar 2025) to 1.30%, marking an increase of 1.27%.
• For Other Income, as of Jun 2025, the value is 1.15 Cr.. The value appears to be declining and may need further review. It has decreased from 2.75 Cr. (Mar 2025) to 1.15 Cr., marking a decrease of 1.60 Cr..
• For Interest, as of Jun 2025, the value is 0.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.67 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.05 Cr..
• For Depreciation, as of Jun 2025, the value is 0.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.02 Cr. (Mar 2025) to 0.91 Cr., marking a decrease of 0.11 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.64 Cr.. The value appears to be declining and may need further review. It has decreased from 1.09 Cr. (Mar 2025) to 0.64 Cr., marking a decrease of 0.45 Cr..
• For Tax %, as of Jun 2025, the value is 15.62%. The value appears to be improving (decreasing) as expected. It has decreased from 80.73% (Mar 2025) to 15.62%, marking a decrease of 65.11%.
• For Net Profit, as of Jun 2025, the value is 0.54 Cr.. The value appears strong and on an upward trend. It has increased from 0.21 Cr. (Mar 2025) to 0.54 Cr., marking an increase of 0.33 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.01. The value appears strong and on an upward trend. It has increased from 0.00 (Mar 2025) to 0.01, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:10 pm

Growth

Last Updated: September 5, 2025, 7:45 am

Balance Sheet

Last Updated: June 16, 2025, 11:56 am

Below is a detailed analysis of the balance sheet data for Integra Essentia Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Mar 2024) to 107.00 Cr., marking an increase of 16.00 Cr..
• For Reserves, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 37.00 Cr..
• For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 19.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 25.00 Cr.. The value appears to be improving (decreasing). It has decreased from 77.00 Cr. (Mar 2024) to 25.00 Cr., marking a decrease of 52.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 221.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 201.00 Cr. (Mar 2024) to 221.00 Cr., marking an increase of 20.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 15.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 29.00 Cr., marking a decrease of 7.00 Cr..
• For Other Assets, as of Mar 2025, the value is 139.00 Cr.. The value appears strong and on an upward trend. It has increased from 128.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 11.00 Cr..
• For Total Assets, as of Mar 2025, the value is 221.00 Cr.. The value appears strong and on an upward trend. It has increased from 201.00 Cr. (Mar 2024) to 221.00 Cr., marking an increase of 20.00 Cr..

Notably, the Reserves (63.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Integra Essentia Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.28. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 23) to 0.28, marking an increase of 0.13.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 0.35 (Mar 23) to 0.28, marking a decrease of 0.07.
• For Cash EPS (Rs.), as of Mar 24, the value is 0.20. This value is below the healthy minimum of 3. It has increased from 0.14 (Mar 23) to 0.20, marking an increase of 0.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.28. It has decreased from 1.65 (Mar 23) to 1.28, marking a decrease of 0.37.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.28. It has decreased from 1.65 (Mar 23) to 1.28, marking a decrease of 0.37.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 3.03. It has decreased from 5.28 (Mar 23) to 3.03, marking a decrease of 2.25.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.25. This value is below the healthy minimum of 2. It has increased from 0.15 (Mar 23) to 0.25, marking an increase of 0.10.
• For PBIT / Share (Rs.), as of Mar 24, the value is 0.21. This value is within the healthy range. It has increased from 0.15 (Mar 23) to 0.21, marking an increase of 0.06.
• For PBT / Share (Rs.), as of Mar 24, the value is 0.20. This value is within the healthy range. It has increased from 0.15 (Mar 23) to 0.20, marking an increase of 0.05.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.16. This value is below the healthy minimum of 2. It has increased from 0.14 (Mar 23) to 0.16, marking an increase of 0.02.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.16. This value is below the healthy minimum of 2. It has increased from 0.14 (Mar 23) to 0.16, marking an increase of 0.02.
• For PBDIT Margin (%), as of Mar 24, the value is 8.38. This value is below the healthy minimum of 10. It has increased from 2.98 (Mar 23) to 8.38, marking an increase of 5.40.
• For PBIT Margin (%), as of Mar 24, the value is 7.04. This value is below the healthy minimum of 10. It has increased from 2.97 (Mar 23) to 7.04, marking an increase of 4.07.
• For PBT Margin (%), as of Mar 24, the value is 6.84. This value is below the healthy minimum of 10. It has increased from 2.97 (Mar 23) to 6.84, marking an increase of 3.87.
• For Net Profit Margin (%), as of Mar 24, the value is 5.51. This value is within the healthy range. It has increased from 2.73 (Mar 23) to 5.51, marking an increase of 2.78.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.56. This value is below the healthy minimum of 8. It has increased from 2.76 (Mar 23) to 5.56, marking an increase of 2.80.
• For Return on Networth / Equity (%), as of Mar 24, the value is 13.17. This value is below the healthy minimum of 15. It has increased from 8.84 (Mar 23) to 13.17, marking an increase of 4.33.
• For Return on Capital Employeed (%), as of Mar 24, the value is 15.66. This value is within the healthy range. It has increased from 6.90 (Mar 23) to 15.66, marking an increase of 8.76.
• For Return On Assets (%), as of Mar 24, the value is 7.65. This value is within the healthy range. It has increased from 4.14 (Mar 23) to 7.65, marking an increase of 3.51.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.37 (Mar 23) to 0.06, marking a decrease of 0.31.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.06. This value is within the healthy range. It has decreased from 0.37 (Mar 23) to 0.06, marking a decrease of 0.31.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.53. It has increased from 0.00 (Mar 23) to 1.53, marking an increase of 1.53.
• For Current Ratio (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1.5. It has increased from 0.31 (Mar 23) to 0.76, marking an increase of 0.45.
• For Quick Ratio (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 23) to 0.76, marking an increase of 0.45.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 41.29. This value is within the healthy range. It has decreased from 3,791.00 (Mar 23) to 41.29, marking a decrease of 3,749.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 28.17. This value is within the healthy range. It has decreased from 3,477.16 (Mar 23) to 28.17, marking a decrease of 3,448.99.
• For Enterprise Value (Cr.), as of Mar 24, the value is 309.80. It has increased from 299.02 (Mar 23) to 309.80, marking an increase of 10.78.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. It has decreased from 1.24 (Mar 23) to 1.12, marking a decrease of 0.12.
• For EV / EBITDA (X), as of Mar 24, the value is 13.33. This value is within the healthy range. It has decreased from 41.51 (Mar 23) to 13.33, marking a decrease of 28.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.10. This value is within the healthy range. It has decreased from 1.14 (Mar 23) to 1.10, marking a decrease of 0.04.
• For Price / BV (X), as of Mar 24, the value is 2.60. This value is within the healthy range. It has decreased from 3.66 (Mar 23) to 2.60, marking a decrease of 1.06.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.10. This value is within the healthy range. It has decreased from 1.14 (Mar 23) to 1.10, marking a decrease of 0.04.
• For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness